Darmstadt, January 28, 2014 – E. Merck KG, Darmstadt, Germany, which combines the financial interests of the Merck family and is general partner of Merck KGaA, Darmstadt, Germany, with an interest of 70%, announced today that at this year's General Partners' Meeting, the family partners elected their representatives to the Family Board, which is the supervisory body of E. Merck KG, Darmstadt, Germany.
Dr. Frank Stangenberg-Haverkamp (65) has been elected as the new Chairman of the twelve-member Family Board. Jon Baumhauer (69), previously Chairman of the Family Board and Chairman of the Executive Board of E. Merck KG, Darmstadt, Germany, has retired from his offices for age reasons.
“For decades, Jon Baumhauer has uniquely shaped and successfully led the company and the Merck family of owners. The partners are exceptionally grateful to him for his leadership of the community of family members and for familiarizing the next generation with the company,” said Stangenberg-Haverkamp, praising the achievements of his predecessor.
Baumhauer was elected to the Board of Partners of E. Merck KG, Darmstadt, Germany, in 1979. In 1989 he became Vice Chairman of this body and from 1994 to 2004 he served as Chairman of the Board of Partners. In 2004, he took over the chairmanship of the Family Board.
The Family Board newly appointed the nine members of the Board of Partners of E. Merck KG, Darmstadt, Germany, . The Board of Partners is comparable to the supervisory board of a German stock corporation (AG). It supervises the executive management of Merck KGaA, Darmstadt, Germany, and is responsible for the appointment Executive Board members of Merck KGaA, Darmstadt, Germany.
Johannes Baillou (48) has been elected Chairman of the Board of Partners. He has been a member of the Board of Partners since 2009 and served as Vice Chairman of this body since then. Stangenberg-Haverkamp, who has been a member of the Board of Partners since 1984, has been elected Vice Chairman. In addition, Dr. Wolfgang Büchele (54), Dr. Siegfried Karjetta (59), Albrecht Merck (64), Prof. Dr. Helga Rübsamen-Schaeff (65), Prof. Dr. Gregor Schulz (63), Prof. Dr. Theo Siegert (66), and Tobias Thelen (37) have been elected to the Board of Partners.